EPAS1 and renal cell carcinoma: Studies have revealed AR involvement in promoting the RCC metastasis route through the modulation of the angiogenesis-related factors HIF-2α and VEGF-A against the lymphangiogenesis factors VEGF-C and VEGF-D [78].